BOLLI, NICCOLO'
BOLLI, NICCOLO'
Dipartimento di Oncologia ed Emato-Oncologia
A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes
2017 F. Maura, L. Agnelli, T. Heavican, A. Dodero, C. Carniti, J. Chan, Y. Jiayu, A. Pellegrinelli, A.D. Cabras, N. Bolli, A. Chiappella, D. Leongamornlert, A. Di Rocco, M. Ansuinelli, F. Zaja, U. Vitolo, R. Piva, W. Wang, A. Neri, J. Iqbal, P. Corradini
A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma
2016 N. Bolli, Y. Li, V. Sathiaseelan, K. Raine, D. Jones, P. Ganly, F. Cocito, G. Bignell, M.A. Chapman, A.S. Sperling, K.C. Anderson, H. Avet Loiseau, S. Minvielle, P.J. Campbell, N.C. Munshi
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF
2009 N. Bolli, M.F. De Marco, M.P. Martelli, B. Bigerna, A. Pucciarini, R. Rossi, R. Mannucci, N. Manes, V. Pettirossi, S.A. Pileri, I. Nicoletti, B. Falini
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
2019 B.A. Walker, K. Mavrommatis, C.P. Wardell, T.C. Ashby, M. Bauer, F. Davies, A. Rosenthal, H. Wang, P. Qu, A. Hoering, M. Samur, F. Towfic, M. Ortiz, E. Flynt, Z. Yu, Z. Yang, D. Rozelle, J. Obenauer, M. Trotter, D. Auclair, J. Keats, N. Bolli, M. Fulciniti, R. Szalat, P. Moreau, B. Durie, A.K. Stewart, H. Goldschmidt, M.S. Raab, H. Einsele, P. Sonneveld, J. San Miguel, S. Lonial, G.H. Jackson, K.C. Anderson, H. Avet-Loiseau, N. Munshi, A. Thakurta, G. Morgan
A Journey Through Myeloma Evolution : From the Normal Plasma Cell to Disease Complexity
2020 M.C. Da Vià, B. Ziccheddu, A. Maeda, F. Bagnoli, G. Perrone, N. Bolli
A new case of myelodysplastic syndrome associated with t(3;3)(q21;q26) and inv(11)(p15q22)
2020 V. Monti, F. Bagnoli, N. Bolli, L. Vittoria, S. Stioui, M.L. Moiraghi, G. Pruneri, M.A. Testi
A Next Generation Sequencing-Based Approach to Detect Gene Mutations, Copy Number Changes and IGH Translocations in Multiple Myeloma
2014 N. Bolli, G. R Bignell, P. Ganly, E. Papaemmanuil, H. Avet-Loiseau, A. Sperling, S. Minvielle, P. J Campbell, N.C. Munshi
A novel in-house deep sequencing method for non-invasive disease monitoring in multiple myeloma patients
2017 C. Carniti, G. Biancon, S. Gimondi, A. Vendramin, A. Bermema, S. Rizzitano, M. Magni, N. Bolli, V. Montefusco, P. Corradini
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
2008 A. Liso, F. Castiglione, A. Cappuccio, F. Stracci, R.F. Schlenk, S. Amadori, C. Thiede, S. Schnittger, P.J..M. Valk, K. Döhner, M.F. Martelli, M. Schaich, J. Krauter, A. Ganser, M.P. Martelli, N. Bolli, B. Löwenberg, T. Haferlach, G. Ehninger, F. Mandelli, H. Döhner, F. Michor, B. Falini
A practical guide for mutational signature analysis in hematological malignancies
2019 F. Maura, A. Degasperi, F. Nadeu, D. Leongamornlert, H. Davies, L. Moore, R. Royo, B. Ziccheddu, X.S. Puente, H. Avet-Loiseau, P.J. Cambell, S. Nik-Zainal, E. Campo, N. Munshi, N. Bolli
A rare biclonal Hairy Cell Leukemia disclosed by an integrated diagnostic approach : a case report
2020 L. Vittoria, F. Bozzi, I. Capone, C. Carniti, D. Lorenzini, M. Gobbo, N. Bolli, A. Aiello
A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome
2017 M. Soldarini, L. Farina, A. Genderini, N. Bolli
A targeted sequencing approach in multiple myeloma reveals a complex landscape of genomic lesions that has implications for prognosis
2016 N. Bolli, G. Biancon, S. Gimondi, Y. Li, V. Sathiaseelan, F. Maura, C. Carniti, M. Fulciniti, R. Szalat, K. Anderson, S. Minvielle, M. Attal, P. Moreau, P. Campbell, H. Avet-Loiseau, N. Munshi
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia
2008 M.P. Martelli, N. Manes, A. Liso, V. Pettirossi, B. Verducci Galletti, B. Bigerna, A. Pucciarini, M.F. De Marco, M.T. Pallotta, N. Bolli, M. Sborgia, F. di Raimondo, F. Fabbiano, G. Meloni, G. Specchia, M.F. Martelli, B. Falini
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML
2006 B. Falini, B. Bigerna, A. Pucciarini, E. Tiacci, C. Mecucci, S.W. Morris, N. Bolli, R. Rosati, S. Hanissian, Z. Ma, Y. Sun, E. Colombo, D.A. Arber, R. Pacini, R. La Starza, B. Verducci Galletti, A. Liso, M.P. Martelli, D. Diverio, P.G. Pelicci, F. Lo Coco, M.F. Martelli
Abnormalities in Mitochondrial DNA Copy Number Have Pathogenetic and Prognostic Implications in Multiple Myeloma
2017 Y. Ruiz-Heredia, M. Kemal Samur, A. Ortiz-Ruiz, R. Alonso Fernández, B. Sanchez-Vega, A. Blazquez, A. Delmiro, J. Carlos Martinez-Avila, E. Onecha, A. Valeri, M. Angel Martin, N. Bolli, Y. Tai, F. Maura, R. Szalat, M. Fulciniti, M. Linares, M. Gallardo, P. J Campbell, H. Avet-Loiseau, J. Jose Lahuerta, N. Munshi and Joaquin Martinez-Lopez
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations : implications for the cell of origin of NPMc+ AML [4]
2008 M.P. Martelli, N. Manes, V. Pettirossi, A. Liso, R. Pacini, R. Mannucci, T. Zei, N. Bolli, F. di Raimondo, G. Specchia, I. Nicoletti, M.F. Martelli, B. Falini
Acute myeloid leukemia with mutated nucleophosmin (NPM1) : is it a distinct entity?
2011 B. Falini, M. Martelli, N. Bolli, P. Sportoletti, A. Liso, E. Tiacci, T. Haferlach
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: Molecular basis and clinical implications
2009 B. Falini, N. Bolli, A. Liso, M.P. Martelli, R. Mannucci, S. Pileri, I. Nicoletti
Analysis of different biological factors in patients affected by peripheral T-cell lymphomas not otherwise specified: GATA-3 expression is associated to refractory disease and poor outcome
2016 A. Dodero, F. Maura, A. Pellegrinelli, A. Chiappella, A. Cabras, P. Zinzani, D. Novero, F. Zaja, E. Sabbatini, S. Pizzolitto, C. Carniti, U. Vitolo, N. Bolli, P. Corradini